On World AIDS Day 2014, mayors from around the world came together in Paris, France, to sign declaration to end AIDS epidemic in their cities.
PRO 140 may prove to be a potential new therapy for HIV patients who need to cycle off conventional treatment regimens.
Cryptococcosis is an infection caused by inhaling the fungus Cryptococcus Neoformans and most often affects people with AIDS.
Edurant is used in combination with other anti-retroviral drugs for the treatment of HIV 1 infection in adults.
This year HIV Vaccine Awareness Day comes at the dawn of a true prevention revolution that could finally turn the tide of the AIDS epidemic.
HIV adapts in a surprising way to survive and thrive in its hiding spot within the human immune system.
The rise in strokes among HIV patients was entirely driven by an increase in ischemic strokes.
The World Bank Yale survey found that people with disabilities engage in behaviors that carry a risk of HIV infection.
Despite Progress in Testing Americans for HIV a Lack of Federal and Private Insurance Impedes Expansion.
HERVs human endogenous retroviruses might provide explanations that have been overlooked for 20 years.
HIV-infected children receiving highly active anti-retroviral therapy (HAART) may require revaccination to maintain immunity against preventable diseases.
Researchers at the University of Minnesota Academic Health Center have identified two drugs that, when combined, may serve as an effective treatment for HIV..
Promising new anti HIV drug candidate PIE12-trimer prevents HIV from attacking human cells.
New research could empower women to lower risk of HIV infection highlights intersection of science and human rights.
WHO and UNAIDS recommend adult male circumcision as an effective HIV prevention intervention.
The earlier people are diagnosed with HIV and get access to care the better their clinical outcomes.
Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years.
Interactive CD Live Safe preventing HIV and AIDS for Women with Intellectual Disabilities.
Researchers from Thomas Jefferson University are one step closer to developing a vaccine against the AIDS disease.
Researchers have uncovered a possible method for eradicating HIV infection in the human body and how the virus replicates itself in individuals undergoing treatment.
Conventional wisdom says several years will pass between HIV infection and the need for anti-retroviral therapy.
Rutgers AIDS researchers Gail Ferstandig Arnold and Eddy Arnold may have turned a corner in their search for a HIV vaccine.
Data collected from HIV surveillance are crucial to guide public health interventions planning and prevention efforts.
HIV culture tests are used to detect the presence of the human immunodeficiency virus such tests may detect HIV antibodies antigens or RNA.
Women also experience HIV associated gynecologic problems many of which occur in uninfected women but with less frequency or severity.
Researchers reveal a surprising Aids and HIV virus health scandal and lack of public awareness.